---
title: "Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in US"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293462534.md"
description: "Johnson & Johnson has received FDA De Novo clearance for its OTTAVA robotic surgery system in the U.S. The device is approved for various upper-abdominal general surgeries, including bariatric procedures, gallbladder removal, and appendectomies. The company intends to launch commercially with select customers while seeking additional indications."
datetime: "2026-07-22T11:04:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293462534.md)
  - [en](https://longbridge.com/en/news/293462534.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293462534.md)
---

# Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in US

-   FDA granted De Novo market authorization for Johnson & Johnson’s OTTAVA robotic surgical system in the U.S. \* Cleared for multiple upper-abdominal general surgery procedures, including bariatric surgery, gallbladder removal, appendectomy. \* Company plans a limited U.S. commercial launch with select customers while pursuing additional indications. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 202607220700BIZWIRE\_USPR\_\_\_\_\_20260717\_BW254564) on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [EXPLAINER-Can J&J finally put the talc litigation behind it?](https://longbridge.com/en/news/294232224.md)
- [J&J Strikes $5.5B Talc Settlement after Years of Lawsuits; JNJ Stock Rises](https://longbridge.com/en/news/294022902.md)
- [Johnson & Johnson offers £4.1bn to settle talcum powder cancer claims](https://longbridge.com/en/news/294049280.md)
- [BUZZ-Street View: J&J's strongest talc settlement push yet could clear legal cloud](https://longbridge.com/en/news/294044207.md)
- [14:16 ETMilberg Helps Deliver Historic Uncapped Settlement for 70,000 Women in J&J Talcum Powder Litigation](https://longbridge.com/en/news/294100515.md)